author-photo

Eric Bleickardt

Novartis

10

Papers

198

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.

2021 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma.

2020 Blood Advances
Show All
- Source
- Cite
- Save
Citations (54)
Industry’s Giant Leap Into Cellular Therapy: Catalyzing Chimeric Antigen Receptor T Cell (CAR-T) Immunotherapy

2019 Current Hematologic Malignancy Reports
Show All
- Source
- Cite
- Save
Citations (6)
Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Children and Young Adults with Acute Lymphoblastic Leukemia (ALL): Real World Experience from the Center for International Blood and Marrow Transplant Research (CIBMTR) and Cellular Therapy (CT) Registry

2019 Blood
Show All
- Source
- Cite
- Save
Citations (19)
Abstract CT237: Evaluation of in vivo chimeric antigen receptor (CAR) transgene levels in patients (pts) treated with tisagenlecleucel

2019 Clinical Trials
Show All
- Source
- Cite
- Save
Citations (0)
Updated Analysis of the Efficacy and Safety of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed/Refractory (r/r) Acute Lymphoblastic Leukemia

2018 Blood
Show All
- Source
- Cite
- Save
Citations (49)